FDA nagbabala laban sa mga hindi rehistradong produkto

By Angellic Jordan October 09, 2019 - 11:47 PM

Nagbabala ang Food and Drug Administration (FDA) sa publiko laban sa mga hindi rehistradong produkto.

Sa inilabas na pahayag, sinabi ng FDA na posibleng magdulot ng panganib sa kalusugan ang nasa labing-dalawang food supplement.

Hindi kasi anila dumaan sa evaluation process ng FDA ang mga produkto.

Kabilang dito ang mga sumusunod:

– PREVAILMAX™ Cellular Homeostasis Formula

– FUCOIDAN (Prevent Cancer, Anti-Tumor, Anti-Inflammatory Booster)

– SOZO KETO BOOST BHB Ketones Advanced Weight Loss Dietary Supplement 60 capsules (100mg)

– HM Long Jack Tongkat Ali 60 capsules (500mg)

– GLUTA PRIMME Authentic Dietary Supplement Product (30 capsules)

– NOW® Phosphatidyl Serine 100mg Cognitive Health with Gingko Biloba Extract Dietary – Supplement Softgels (50 Softgels x bottle)

– LIFEEXTENTION® Rhodiola Extract3% Rosavins 250mg Dietary Supplement Capsules (60 vegetarian capsules x bottle)

– DIARA PITO-PITO Herbal Food Supplement100% Pure Herbal Liquid (375ml per Bottle)

– TEATOX LIFE 100% All Natural Kidney and Bladder Cleanse Tea Loose Leaf Herbal Blend

– TEATOX LIFE 100% All Natural Milk Thistle Powder for Liver Cleanse and Detox Herbal Supplement

– SUCCESS 200 Herbal Food Supplement Serpentina Andrographis Paniculata Capsules

– SUCCESS 200 Guyabano Fruit Extracts,60 Capsules

Sinabi naman ng ahensya na ipinag-utos na sa kanilang mga regional office at enforcement unit na tiyaking hindi maibebenta sa merkado ang mga produkto.

 

TAGS: Babala, FDA, food supplement, hindi rehistrado, kalusugan, mapanganib, Babala, FDA, food supplement, hindi rehistrado, kalusugan, mapanganib

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.